Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
E-pub ahead of print

GIP's involvement in the pathophysiology of type 2 diabetes

Research output: Contribution to journalReviewResearchpeer-review

  1. Serum proatrial natriuretic peptide concentrations during oral glucose-induced acute hyperinsulinemia in lean and obese men

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cardiac procholecystokinin expression during haemodynamic changes in the mammalian heart

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Wavy multistratified amacrine cells in the monkey retina contain immunoreactive secretoneurin

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Analgesics use and withdrawal in people with dementia - a register-based Danish study and a systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion - A Review

    Research output: Contribution to journalReviewResearchpeer-review

  4. Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

During the past four decades derangements in glucose-dependent insulinotropic polypeptide (GIP) biology has been viewed upon as contributing factors to various parts of the pathophysiology type 2 diabetes. This overview outlines and discusses the impaired insulin responses to GIP as well as the effect of GIP on glucagon secretion and the potential involvement of GIP in obesity and bone disease associated with type 2 diabetes. As outlined in this review, it is unlikely that impaired insulinotropic effects of GIP occur as a primary event in the development of type 2 diabetes, but rather develop once the diabetic state is present and beta cells are unable to maintain normoglycemia. In various models, GIP has effects on glucagon secretion, bone and lipid homeostasis, but whether these effects contribute substantially to the pathophysiology of type 2 diabetes is at present controversial. The review also discusses the substantial uncertainty surrounding the translation of preclinical data relating to the GIP system and outline future research directions.

Original languageEnglish
JournalPeptides
ISSN0196-9781
DOIs
Publication statusE-pub ahead of print - 1 Nov 2019

ID: 58295673